Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Key Moments

  • Equifax shares rose 1.5% in pre-market trading after reporting third-quarter 2026 adjusted EPS of $2.26, above the roughly $2.20 analyst consensus.
  • Q3 2026 revenue reached $1.69 billion, in line with expectations and up 10% year-over-year, while net income increased 32% to $211.7 million.
  • Despite trimming full-year revenue and EPS guidance amid ongoing mortgage market weakness, reduced short interest and a solid quarter supported the stock.

Headline Beat Lifts Shares

Equifax stock gained 1.5% in pre-open trading after the company delivered third-quarter 2026 results that were better than anticipated on the bottom line. The credit data and analytics company reported adjusted earnings per share of $2.26, topping the analyst consensus of approximately $2.20 and extending its run of consecutive quarterly beats.

Revenue for the quarter came in at $1.69 billion, matching expectations. Sales grew 10% compared with the same period a year earlier, while net income jumped 32% to $211.7 million. The performance highlighted the robustness of Equifax’s diversified operations, even as the U.S. mortgage market weakened sharply in the latter part of the quarter.

Guidance Sends Mixed Signals

The company’s outlook presented a more nuanced picture. For the fourth quarter of 2026, Equifax projected EPS of $2.07–$2.17, slightly below the Wall Street consensus of $2.18. In addition, the company reduced the midpoint of its full-year revenue forecast to $6.661 billion, pointing to continued softness in mortgage-related activity.

However, the adjustment to earnings expectations was relatively modest. Full-year adjusted EPS guidance was lowered by only $0.04 at the midpoint, a smaller reduction than some investors had anticipated. That limited cut appeared to provide reassurance that mortgage market pressures were not inflicting deeper damage on overall profitability.

MetricQ3 2026 Result / GuidanceMarket ExpectationCommentary
Adjusted EPS$2.26≈ $2.20Beat estimates and extended quarterly beat streak
Revenue$1.69 billion$1.69 billionIn line with consensus, up 10% year-over-year
Net Income$211.7 millionNot specifiedUp 32% year-over-year
Q4 2026 EPS Guidance$2.07–$2.17$2.18Slightly below consensus
Full-year 2026 Revenue Guidance Midpoint$6.661 billionPrior midpoint higher (not specified)Trimmed on ongoing mortgage market softness
Full-year 2026 Adjusted EPS GuidanceMidpoint cut by $0.04Not specifiedSmaller reduction than some investors feared

Positioning and Analyst Actions

Technical factors also supported the move higher. Short interest in Equifax contracted by roughly 31% in the week leading up to the earnings release, signaling that a significant portion of bearish positioning had already been covered before the numbers were announced. That shift helped limit downside pressure and may have amplified the positive reaction to the earnings beat.

The gain in pre-market trading came despite a series of cautious analyst moves ahead of the report. On October 16, Oppenheimer downgraded Equifax from Outperform to Perform, highlighting mortgage market headwinds that account for about 20%–22% of the company’s revenue.

RBC Capital cut its price target before the results, while Morgan Stanley and other firms had also reduced their outlooks in recent weeks. These actions had largely been absorbed by the market prior to the earnings release, leaving the stronger-than-expected third-quarter performance as the main driver of the stock’s latest move.

Business Performance Amid Mortgage Weakness

The third-quarter update painted a picture of a company managing through a difficult sector backdrop. Equifax showed that it could expand both revenue and margins despite the pronounced slowdown in the U.S. mortgage market late in the quarter.

The Diversified Markets segment recorded 8% growth, demonstrating that other parts of the business continued to perform well and offset some of the mortgage drag. In addition, the company reported that its new product Vitality Index reached a record level above 17%, emphasizing the contribution of newer offerings to overall growth.

Market Context and Investor Takeaways

Broader equities provided little support, with the S&P 500 and Nasdaq both trading modestly lower on the day. Against that backdrop, Equifax’s pre-market rise stood out, driven primarily by company-specific news.

Overall, investors were left with a story that was better than many had feared. The combination of a clear earnings beat, relatively restrained guidance cuts, reduced short interest, and steady performance from diversified and new product areas was sufficient to lift the stock, even as the mortgage outlook remains difficult heading into year-end.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News